Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 3Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Plasma cell 2Myeloid 2Lymphoid 2Classical hematology 1

Conditions

Leukemia 103Leukemia, Myeloid, Acute 93Myelodysplastic Syndromes 84Lymphoma 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Lymphoma, Non-Hodgkin 58Multiple Myeloma 57Hodgkin Disease 52Leukemia, Lymphocytic, Chronic, B-Cell 49Congenital Abnormalities 46Leukemia, Myeloid, Chronic-Phase 42Lymphoma, Large B-Cell, Diffuse 40Neoplasms, Plasma Cell 39Lymphoma, Follicular 39Myeloproliferative Disorders 38Leukemia, Myelomonocytic, Chronic 37Leukemia, Myeloid, Accelerated Phase 37Lymphoma, Mantle-Cell 35Lymphoma, Large-Cell, Immunoblastic 33Lymphoma, B-Cell, Marginal Zone 33Burkitt Lymphoma 33Blast Crisis 32Anemia, Refractory, with Excess of Blasts 31Primary Myelofibrosis 28Recurrence 23Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 23Dendritic Cell Sarcoma, Interdigitating 23Myelodysplastic-Myeloproliferative Diseases 22Lymphoma, T-Cell, Cutaneous 20

Interventions

Cytarabine 9fludarabine 5Imatinib Mesylate 5thymoglobulin 3fludarabine phosphate 3Tacrolimus 3Sirolimus 3Methotrexate 3Cyclophosphamide 3Busulfan 3Azacitidine 3zosuquidar trihydrochloride 2venetoclax 2ponatinib 2nilotinib 2enasidenib 2bosutinib 2RO6839921 2Mycophenolic Acid 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Behavior Therapy 2Antilymphocyte Serum 24-methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-pyrazin-2-ylpyrimidin-2-ylamino)benzamide 2spartalizumab 1sabatolimab 1quizartinib 1plerixafor 1pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid × Busulfan × Clear all
NCT01760655 2025-10-30

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Thomas Jefferson University

Phase 2 Completed
62 enrolled 15 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Leukemia, Myeloid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT01050036 2025-03-17

Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia

Asan Medical Center

Phase NA Completed
20 enrolled
Other hematologic neoplasm

Leukemia, Myeloid

NCT02916979 2023-10-18

FluBuATG

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
20 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡